Contribution of alcohol use to the global burden of cirrhosis and liver cancer from 1990 to 2019 and projections to 2044

被引:20
|
作者
Liu, Yang [1 ]
Sun, Zhouyi [1 ]
Wang, Qianwen [1 ]
Wu, Kangze [2 ]
Tang, Zhe [1 ]
Zhang, Bo [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 4, Sch Med, Yiwu 322000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Alcohol use; Cirrhosis; Liver cancer; Socioeconomics; Epidemiology; Public health; Global burden of disease; Liver disease; Age-standardized rate; Disability-adjusted life-years; SUB-SAHARAN AFRICA; RISK-FACTORS; DISEASE; CONSUMPTION; MORTALITY; HEPATITIS; SMOKING; AGE;
D O I
10.1007/s12072-023-10503-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundIdentifying the temporal trends of cirrhosis and liver cancer attributable to alcohol use in both the past and the future can formulate the control strategies.MethodsData on cirrhosis and liver cancer attributable to alcohol use from 1990 to 2019, including mortality and disability-adjusted life year (DALY) rates were collected from the 2019 Global Burden of Disease (GBD) study. To analyze the temporal trends, the average annual percentage change (AAPC) was calculated, and the Bayesian age-period-cohort model was applied.ResultDeaths and DALY of cirrhosis and liver cancer attributable to alcohol use increased year by years, but the age-standardized death rate (ASDR) and age-standardized DALY rate declined or remained stable from 1990 to 2019 in most regions of the world. The burden of cirrhosis attributable to alcohol increased in low-middle social-development index (SDI) regions, while the burden of liver cancer increased in high-SDI regions. Eastern Europe and Central Asia have the highest burden of cirrhosis and liver cancer caused by alcohol use. Deaths and DALYs are mainly distributed in people aged 40+ years, but there is an increasing trend in people aged under 40 years. New deaths from cirrhosis and liver cancer attributable to alcohol use are predicted to increase in the next 25 years, but the ASDR of cirrhosis in males will increase slightly.ConclusionsAlthough the age-standardized rate of cirrhosis and liver cancer due to alcohol use have decreased, the absolute burden increased and will continue to increase. Therefore, alcohol control measures should be further strengthened and improved through effective national policies.
引用
收藏
页码:1028 / 1044
页数:17
相关论文
共 50 条
  • [41] The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019
    Xu, Shangbo
    Liu, Yiyuan
    Zhang, Taofeng
    Zheng, Jiehua
    Lin, Weixun
    Cai, Jiehui
    Zou, Juan
    Chen, Yaokun
    Xie, Yanna
    Chen, Yexi
    Li, Zhiyang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019
    Ghamari, Seyyed-Hadi
    Yoosefi, Moein
    Abbasi-Kangevari, Mohsen
    Malekpour, Mohammad-Reza
    Moghaddam, Sahar Saeedi
    Shahin, Sarvenaz
    Esfahani, Zahra
    Koolaji, Sogol
    Shobeiri, Parnian
    Ghaffari, Aydin
    Sohrabi, Hanye
    Kazemi, Ameneh
    Rezaei, Negar
    Larijani, Bagher
    Farzadfar, Farshad
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1764 - 1775
  • [43] STATEWIDE BURDEN OF LUNG CANCER ATTRIBUTABLE TO SMOKING IN UNITED STATES FROM 1990-2019 PROJECTIONS OF DEATHS TO 2040: INSIGHTS FROM THE GLOBAL BURDEN OF DISEASE STUDY 2019
    Banerjee, Amit
    Ratheesh, Rani
    Enemuo, Nkechi
    Vala, Lovekumar
    Sojitra, Vani
    Abuhashem, Shadi
    Faris, Khalid
    Modi, Dhruvi
    Patel, Krina Manojbhai
    Desai, Hardik Dineshbhai
    CHEST, 2024, 166 (04) : 6253A - 6254A
  • [44] Global burden of type 2 diabetes mellitus from 1990 to 2021, with projections of prevalence to 2044: a systematic analysis across SDI levels for the global burden of disease study 2021
    He, Ke-Jie
    Wang, Haitao
    Xu, Jianguang
    Gong, Guoyu
    Liu, Xu
    Guan, Huiting
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [45] The global burden and associated factors of ovarian cancer in 1990-2019: findings from the Global Burden of Disease Study 2019
    Zhang, Shiwen
    Cheng, Chen
    Lin, Zejian
    Xiao, Linzi
    Su, Xin
    Zheng, Lu
    Mu, Yingjun
    Liao, Minqi
    Ouyang, Ruiqing
    Li, Wanlin
    Ma, Junrong
    Cai, Jun
    Liu, Lu
    Wang, Donghong
    Zeng, Fangfang
    Liu, Jun
    BMC PUBLIC HEALTH, 2022, 22 (01) : 1455
  • [46] Global, Regional, and National Burden of Pancreatic Cancer, 1990-2019: Results from the Global Burden of Disease Study 2019
    Kan, Chengxia
    Liu, Na
    Zhang, Kexin
    Wu, Di
    Liang, Yunzi
    Cai, Weiqin
    Jing, Qi
    Han, Fang
    Xing, Shunjie
    Sun, Xiaodong
    ANNALS OF GLOBAL HEALTH, 2023, 89 (01): : 1 - 14
  • [47] The Global Burden of Primary Liver Cancer From 1990 to 2019: A Population-Based Time-Trend Insights Using the Global Burden of Diseases Study 2019
    Jaber, Fouad
    Alsakarneh, Saqr
    Mittal, Anika
    Abughazaleh, Saeed
    Alzghoul, Hamza
    Beran, Azizullah
    Ahmed, Mohamed
    Jaber, Mohammad
    Al-Sayyed, Leen
    Abdelfattah, Thaer
    Abushamma, Suha
    Wilson, Natalie
    Kilani, Yassine
    Zulqarnain, Mir
    Helzberg, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1015 - S1016
  • [48] Burden of Prostate Cancer in China, 1990-2019: Findings From the 2019 Global Burden of Disease Study
    Wang, Fuquan
    Wang, Chenchen
    Xia, Haifa
    Lin, Yun
    Zhang, Dingyu
    Yin, Peng
    Yao, Shanglong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [49] Burden of Lung Cancer in China, 1990-2019: Findings from the Global Burden of Disease Study 2019
    Sun, Huixin
    Zhang, Haiyu
    Cai, Huilong
    Yuan, Weiguang
    Wang, Fengjiao
    Jiang, Yang
    Gu, Xinyue
    Kang, Ziman
    Kang, Yue
    CANCER CONTROL, 2023, 30
  • [50] Changes in the disease burden of breast cancer along with attributable risk factors in China from 1990 to 2019 and its projections: An analysis of the global burden of disease study 2019
    Li, Jie
    Chen, Cui
    Nie, Jinjin
    Wang, Lili
    Zhang, Zhen
    Li, Yuli
    CANCER MEDICINE, 2023, 12 (02): : 1888 - 1902